Company & Sponsor Intelligence

Oregon Health and Science University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials19

Recruiting2

Completed13

Countries1

Therapeutic footprint

adhdalzheimersautismepilepsymovement_disordersmultiple_sclerosisother_neurologypain_neuropathyparkinsons

Indexed studies

NCT03252522Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
adhd · United StatesPHASE1, PHASE2

NCT01003002Natural History of Levodopa-Induced Dyskinesia (LID)
parkinsons · United StatesWITHDRAWN

NCT06908187Opt-In Early Pilot Study
autism · United StatesNA

NCT01904708Moderate Intensity Exercise and Phenylketonuria
other_neurology · United StatesNA

NCT01399905High and Low Dose Carbidopa Treatment of Parkinson's Disease
parkinsons · United StatesPHASE2

NCT04627662Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA
alzheimers · United StatesNA

NCT00212745Pilot Trial of a Behavioral Treatment for Epilepsy
epilepsy · United StatesPHASE1, PHASE2

NCT01579669Partnering With Autistic Adults to Improve Healthcare
autism · United StatesNA

NCT01058941Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease
alzheimers · United StatesPHASE1, PHASE2

NCT02206620Effects of Cholinergic Augmentation on Measures of Balance and Gait
parkinsons · United StatesPHASE2

NCT04686838REmote Assessment and Dynamic Response Intervention II
alzheimers · United StatesNA

NCT05260515Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
alzheimers · PHASE1, PHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →